{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:28:40Z","timestamp":1793406520108,"version":"4.5.0"},"reference-count":186,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008414","name":"University of Canterbury","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001530","name":"Canterbury Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) affects up to 20% of women but remains poorly understood. It is a heterogeneous condition with many potential comorbidities. This review offers an overview of the dysregulation of the reproductive and metabolic systems associated with PCOS. Review of the literature informed the development of a comprehensive summarizing \u2018wiring\u2019 diagram of PCOS-related features. This review provides a justification for each diagram aspect from the relevant academic literature, and explores the interactions between the hypothalamus, ovarian follicles, adipose tissue, reproductive hormones and other organ systems. The diagram will provide an efficient and useful tool for those researching and treating PCOS to understand the current state of knowledge on the complexity and variability of PCOS.<\/jats:p>","DOI":"10.3389\/fendo.2022.1017468","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T02:53:44Z","timestamp":1668480824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":74,"title":["A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions"],"prefix":"10.3389","volume":"13","author":[{"given":"Rebecca H. K.","family":"Emanuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocrine Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110561","article-title":"Pathological pulses in PCOS","volume":"498","author":"Coyle","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13795","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"89","author":"Teede","year":"2018","journal-title":"Clin Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertility Sterility"},{"key":"B5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1210\/rp.56.1.295","article-title":"Insulin resistance in polycystic ovary syndrome: Progress and paradoxes","volume":"56","author":"Venkatesan","year":"2001","journal-title":"Recent Prog Hormone Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic\u2013hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: A systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv052","article-title":"Reply: Polycystic ovary syndrome and pregnancy","volume":"22","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab181","article-title":"Is fertility reduced in ovulatory women with polycystic ovary syndrome? an opinion paper","volume":"36","author":"Palomba","year":"2021","journal-title":"Hum Reprod"},{"key":"B11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/nss.S127475","article-title":"Sleep disturbances in women with polycystic ovary syndrome: Prevalence, pathophysiology, impact and management strategies","volume":"10","author":"Fernandez","year":"2018","journal-title":"Nat Sci Sleep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S300015","article-title":"A comparative study on insulin secretion, insulin resistance and thyroid function in patients with polycystic ovary syndrome with and without hashimoto's thyroiditis","volume":"14","author":"Zhao","year":"2021","journal-title":"Diabetes Metab syndrome Obes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: A systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum Reprod"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14279","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: Clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.08.062","article-title":"Androgens in women: Androgen-mediated skin disease and patient evaluation","volume":"80","author":"Bienenfeld","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13115","article-title":"Highlights of neuroanatomical discoveries of the mammalian gonadotropin-releasing hormone system","volume":"34","author":"Campbell","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0300-595X(86)80021-4","article-title":"Adrenal and gonadal androgen secretion in normal females","volume":"15","author":"Longcope","year":"1986","journal-title":"Clinics Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/REP-14-0517","article-title":"Role of androgens in normal and pathological ovarian function","volume":"149","author":"Walters","year":"2015","journal-title":"Reproduction"},{"key":"B21","first-page":"18","article-title":"The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS","volume":"6","author":"Baculescu","year":"2013","journal-title":"J Med Life"},{"key":"B22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/medsci7080084","article-title":"The role of the brain in the pathogenesis and physiology of polycystic ovary syndrome (PCOS)","volume":"7","author":"Coutinho","year":"2019","journal-title":"Med Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13093","article-title":"The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome","volume":"34","author":"McCartney","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0615-1","article-title":"Curtailing PCOS","volume":"87","author":"Witchel Selma","year":"2020","journal-title":"Pediatr Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","article-title":"Endometrial function in women with polycystic ovary syndrome: A comprehensive review","volume":"27","author":"Palomba","year":"2020","journal-title":"Hum Reprod Update"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.11.008","article-title":"Oocyte competence in women with polycystic ovary syndrome","volume":"28","author":"Palomba","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300688200","article-title":"The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis","volume":"278","author":"Wood","year":"2003","journal-title":"J Biol Chem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.3.7318","article-title":"Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries","volume":"86","author":"Jakimiuk","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.79.4.7962289","article-title":"Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.20883","article-title":"Regulation of granulosa and theca cell transcriptomes during ovarian antral follicle development","volume":"75","author":"Skinner","year":"2008","journal-title":"Mol Reprod Dev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod51.4.766","article-title":"Insulin-like growth factor-I regulation of luteinizing hormone (LH) receptor messenger ribonucleic acid expression and LH-stimulated signal transduction in rat ovarian theca-interstitial cells","volume":"51","author":"Magoffin","year":"1994","journal-title":"Biol Reprod"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det015","article-title":"The relationship of serum anti-mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: A prospective cohort study","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum Reprod"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-4-811","article-title":"Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease","volume":"73","author":"Fauser","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.7.4105","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00263","article-title":"The association between prolactin and metabolic parameters in PCOS women: A retrospective analysis","volume":"11","author":"Yang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: Indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2016.1276555","article-title":"Daytime decrease of prolactin levels is associated with PCOS regardless to nutritional status and other hormones levels","volume":"33","author":"Franik","year":"2017","journal-title":"Gynecological Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1993.tb15170.x","article-title":"Hypersecretion of luteinising hormone: A significant cause of infertility and miscarriage","volume":"100","author":"Balen","year":"1993","journal-title":"BJOG: Int J Obstetrics Gynaecol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0213","article-title":"Estrogen receptor-\u03b2 is critical to granulosa cell differentiation and the ovulatory response to gonadotropins","volume":"146","author":"Couse","year":"2005","journal-title":"Endocrinology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-m\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"B45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.fertnstert.2009.03.004","article-title":"Increased anti-m\u00fcllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization","volume":"94","author":"Desforges-Bullet","year":"2010","journal-title":"Fertility Sterility"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu076","article-title":"The role of AMH in anovulation associated with PCOS: A hypothesis","volume":"29","author":"Homburg","year":"2014","journal-title":"Hum Reprod"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/410348","article-title":"A two-pathway mathematical model of the LH response to GnRH that predicts self-priming","volume":"2013","author":"Evans","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejogrb.2004.06.024","article-title":"PCOS: An ovarian disorder that leads to dysregulation in the hypothalamic\u2013Pituitary\u2013Adrenal axis","volume":"118","author":"Doi","year":"2005","journal-title":"Eur J Obstetrics Gynecology Reprod Biol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/en.2019-00428","article-title":"Neuroendocrine impairments of polycystic ovary syndrome","volume":"160","author":"Ruddenklau","year":"2019","journal-title":"Endocrinology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"New Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.49.030187.002053","article-title":"Central actions of ovarian steroids in the feedback regulation of pulsatile secretion of luteinizing hormone","volume":"49","author":"Karsch","year":"1987","journal-title":"Annu Rev Physiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-2-378","article-title":"Progesterone modulation of pulsatile luteinizing hormone secretion in normal women","volume":"58","author":"Soules","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1326","article-title":"Progesterone increases dynorphin a concentrations in cerebrospinal fluid and preprodynorphin messenger ribonucleic acid levels in a subset of dynorphin neurons in the sheep","volume":"146","author":"Foradori","year":"2005","journal-title":"Endocrinology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1095\/biolreprod.104.033126","article-title":"GABAergic integration of progesterone and androgen feedback to gonadotropin-releasing hormone neurons","volume":"72","author":"Sullivan","year":"2005","journal-title":"Biol Reprod"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.2.4604","article-title":"Polycystic ovary syndrome: Evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and Progesterone1","volume":"83","author":"Pastor","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-984741","article-title":"Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty","volume":"25","author":"Blank","year":"2007","journal-title":"Semin Reprod Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.12.4179","article-title":"Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation","volume":"82","author":"Daniels","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1029","article-title":"Androgens increase gonadotropin-releasing hormone neuron firing activity in females and interfere with progesterone negative feedback","volume":"147","author":"Pielecka","year":"2006","journal-title":"Endocrinology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2011.02145.x","article-title":"Depolarising and hyperpolarising actions of GABAA receptor activation on gonadotrophin-releasing hormone neurones: Towards an emerging consensus","volume":"23","author":"Herbison","year":"2011","journal-title":"J Neuroendocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308058101","article-title":"Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: Implications for a common fertility disorder","volume":"101","author":"Sullivan","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.2304-17.2018","article-title":"Prepubertal development of GABAergic transmission to gonadotropin-releasing hormone (GnRH) neurons and postsynaptic response are altered by prenatal androgenization","volume":"39","author":"Berg","year":"2018","journal-title":"J Neurosci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex086","article-title":"Increased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with polycystic ovary syndrome","volume":"32","author":"Kawwass","year":"2017","journal-title":"Hum Reprod"},{"key":"B64","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1210\/en.2012-1954","article-title":"Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome","volume":"154","author":"Moore","year":"2013","journal-title":"Endocrinology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1073\/pnas.1415038112","article-title":"Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome","volume":"112","author":"Moore","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2359","article-title":"Progesterone inhibition of the hypothalamic gonadotropin-releasing hormone pulse generator: Evidence for varied effects in hyperandrogenemic adolescent girls","volume":"90","author":"Chhabra","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.11.6992","article-title":"Polycystic ovarian syndrome: Evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0005","article-title":"Kisspeptin signaling in the brain","volume":"30","author":"Oakley","year":"2009","journal-title":"Endocrine Rev"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-0022","article-title":"Minireview: Kisspeptin\/Neurokinin B\/Dynorphin (KNDy) cells of the arcuate nucleus: A central node in the control of gonadotropin-releasing hormone secretion","volume":"151","author":"Lehman","year":"2010","journal-title":"Endocrinology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1365","article-title":"Kisspeptin acts directly and indirectly to increase gonadotropin-releasing hormone neuron activity and its effects are modulated by estradiol","volume":"149","author":"Pielecka-Fortuna","year":"2008","journal-title":"Endocrinology"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1159\/000439133","article-title":"Potential clinical use of kisspeptin","volume":"102","author":"Prague","year":"2015","journal-title":"Neuroendocrinology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1597343","article-title":"Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS)","volume":"35","author":"Wang","year":"2019","journal-title":"Gynecological Endocrinol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00298","article-title":"Kisspeptin and polycystic ovary syndrome","volume":"10","author":"Tang","year":"2019","journal-title":"Front Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1305","article-title":"Evidence that dynorphin plays a major role in mediating progesterone negative feedback on gonadotropin-releasing hormone neurons in sheep","volume":"145","author":"Goodman","year":"2004","journal-title":"Endocrinology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0541","article-title":"The Kisspeptin\/Neurokinin B\/Dynorphin (KNDy) cell population of the arcuate nucleus: Sex differences and effects of prenatal testosterone in sheep","volume":"151","author":"Cheng","year":"2010","journal-title":"Endocrinology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx013","article-title":"Is foetal hyperexposure to androgens a cause of PCOS","volume":"23","author":"Filippou","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome","volume":"41","author":"Stener-Victorin","year":"2020","journal-title":"Endocrine Rev"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1530\/REP-09-0415","article-title":"Anti-m\u00fcllerian hormone and polycystic ovary syndrome: A mountain too high","volume":"139","author":"Pellatt","year":"2010","journal-title":"Reproduction"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","article-title":"Anti-m\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells","volume":"96","author":"Pellatt","year":"2011","journal-title":"Fertility sterility"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-m\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-m\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1066","article-title":"Estradiol and regulation of anti-mullerian hormone, inhibin-A, and inhibin-B secretion: Analysis of small antral and preovulatory human follicles\u2019 fluid","volume":"91","author":"Andersen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)02944-2","article-title":"Relationship between serum m\u00fcllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women","volume":"77","author":"Cook","year":"2002","journal-title":"Fertility Sterility"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2386","article-title":"No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies","volume":"90","author":"Hammer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1016296","article-title":"Adrenal involvement in polycystic ovary syndrome","volume":"15","author":"Gonzalez","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0239","article-title":"Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS","volume":"6","author":"Paschou","year":"2017","journal-title":"Endocr Connect"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2006.05.005","article-title":"Steroidogenic alterations and adrenal androgen excess in PCOS","volume":"71","author":"Doi","year":"2006","journal-title":"Steroids"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02256.x","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)","volume":"62","author":"Kumar","year":"2005","journal-title":"Clin Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex308","article-title":"Insulin resistance in a Large cohort of women with polycystic ovary syndrome: A comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes","volume":"32","author":"Tosi","year":"2017","journal-title":"Hum Reprod"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90280-5","article-title":"Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome","volume":"165","author":"Gonzalez","year":"1991","journal-title":"Am J Obstetrics Gynecology"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0634","article-title":"Neurosteroids alter \u0393-aminobutyric acid postsynaptic currents in gonadotropin-releasing hormone neurons: A possible mechanism for direct steroidal control","volume":"144","author":"Sullivan","year":"2003","journal-title":"Endocrinology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01303.x","article-title":"Tissue insulin sensitivity and body weight in polycystic ovary syndrome","volume":"55","author":"Marsden","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","author":"Broekmans","year":"2006","journal-title":"BJOG: Int J Obstetrics Gynaecology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B99","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11892-011-0189-8","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"11","author":"Villa","year":"2011","journal-title":"Curr Diabetes Rep"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.4102\/jir.v4i1.50","article-title":"The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome","volume":"4","author":"Pateguana","year":"2019","journal-title":"J Resistance"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1492","article-title":"Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance","volume":"94","author":"Ciaraldi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.6.4886","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114745","article-title":"Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells","volume":"86","author":"Cara","year":"1990","journal-title":"J Clin Invest"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-2-733","article-title":"Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells","volume":"123","author":"Cara","year":"1988","journal-title":"Endocrinology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.12.8530637","article-title":"Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor","volume":"80","author":"Willis","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199602083340607","article-title":"Hypertension and associated metabolic abnormalities \u2014 the role of insulin resistance and the sympathoadrenal system","volume":"334","author":"Reaven","year":"1996","journal-title":"New Engl J Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.4.821","article-title":"Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity","volume":"48","author":"Westerbacka","year":"1999","journal-title":"Diabetes"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"PloS One"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105829","article-title":"Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats","volume":"208","author":"Cui","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-133","article-title":"Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS)","volume":"11","author":"Baranova","year":"2013","journal-title":"J Trans Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000184145","article-title":"Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production","volume":"42","author":"Cara","year":"1994","journal-title":"Hormone Res Paediatrics"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-69-4-716","article-title":"Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells","volume":"69","author":"Erickson","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-16-3-322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrman","year":"1995","journal-title":"Endocrine Rev"},{"key":"B115","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/humupd\/dmq027","article-title":"Insulin-like growth factor binding protein-1 in PCOS: A systematic review and meta-analysis","volume":"17","author":"Kelly","year":"2010","journal-title":"Hum Reprod Update"},{"key":"B116","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/humrep\/10.1.75","article-title":"Metabolic regulation of androgen production by human thecal cells in vitro","volume":"10","author":"Nahum","year":"1995","journal-title":"Hum Reprod"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1378","article-title":"Role of insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries","volume":"98","author":"Stubbs","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B118","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","article-title":"Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis","volume":"64","author":"Deswal","year":"2018","journal-title":"Syst Biol Reprod Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-3-460","article-title":"Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin","volume":"67","author":"Plymate","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.09.020","article-title":"Sex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome","volume":"316","author":"Pugeat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12905-021-01277-6","article-title":"Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: A prospective cross-sectional study","volume":"21","author":"Neubronner","year":"2021","journal-title":"BMC Women's Health"},{"key":"B122","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1055\/s-2007-970163","article-title":"Influence of body mass index on measured and calculated androgen parameters in adult women with hirsutism and PCOS","volume":"115","author":"Cupisti","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.267","article-title":"The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome","volume":"4","author":"Simons","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3109\/07435800.2015.1094083","article-title":"Thyroid status, insulin sensitivity and glucose tolerance in overweight and obese adults before and after 36 weeks of whey protein supplementation and exercise training","volume":"41","author":"Wright","year":"2016","journal-title":"Endocrine Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00222","article-title":"High thyroid stimulating hormone level is associated with hyperandrogenism in euthyroid polycystic ovary syndrome (PCOS) women, independent of age, BMI, and thyroid autoimmunity: A cross-sectional analysis","volume":"10","author":"Cai","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60165-4","article-title":"Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS","volume":"19","author":"Dittrich","year":"2009","journal-title":"Reprod BioMedicine Online (Reproductive Healthcare Limited)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2010.06.008","article-title":"Polycystic ovary syndrome and autoimmunity","volume":"21","author":"Petr\u00edkov\u00e1","year":"2010","journal-title":"Eur J Internal Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4071735","article-title":"Polycystic ovary syndrome may be an autoimmune disorder","volume":"2016","author":"Mobeen","year":"2016","journal-title":"Scientifica"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05850-0","article-title":"Polycystic ovary syndrome: Epidemiologic assessment of prevalence of systemic rheumatic and autoimmune diseases","volume":"40","author":"Sharmeen","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2008.01736.x","article-title":"Prolactin: A pleiotropic neuroendocrine hormone","volume":"20","author":"Grattan","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biochi.2013.09.023","article-title":"Prolactin and adipose tissue","volume":"97","author":"Carr\u00e9","year":"2014","journal-title":"Biochimie"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2013.12.005","article-title":"Adipose tissue macrophages (ATM) of obese patients are releasing increased levels of prolactin during an inflammatory challenge: A role for prolactin in diabesity","volume":"1842","author":"Bouckenooghe","year":"2014","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"B133","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1210\/jcem-51-2-242","article-title":"Correlation of hyperprolactinemia with altered plasma insulin and gluCAGon: Similarity to effects of late human pregnancy","volume":"51","author":"Gustafson","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02469.x","article-title":"The influences of hyperprolactinemia and obesity on cardiovascular risk markers: Effects of cabergoline therapy","volume":"64","author":"Serri","year":"2006","journal-title":"Clin Endocrinol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.13245","article-title":"PCOS remains a diagnosis of exclusion: A concise review of key endocrinopathies to exclude","volume":"86","author":"Kyritsi","year":"2017","journal-title":"Clin Endocrinol"},{"key":"B136","first-page":"53","article-title":"Prolactin secretion in polycystic ovary syndrome (PCOS)","volume":"36","author":"Szosland","year":"2015","journal-title":"Neuro-endocrinology Lett"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347025","article-title":"Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome","volume":"26","author":"Bahceci","year":"2003","journal-title":"J Endocrinological Invest"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031305","article-title":"Prolactin secretion in healthy adults is determined by gender, age and body mass index","volume":"7","author":"Roelfsema","year":"2012","journal-title":"PloS One"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-13-12","article-title":"Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes","volume":"13","author":"Balbach","year":"2013","journal-title":"BMC endocrine Disord"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1893","article-title":"Circulating prolactin associates with diabetes and impaired glucose regulation: A population-based study","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"B141","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: Enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1080\/09513590802653833","article-title":"Serum resistin and adiponectin levels in women with polycystic ovary syndrome","volume":"25","author":"Yilmaz","year":"2009","journal-title":"Gynecological Endocrinol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-4-42","article-title":"Adipose tissue dysregulation and reduced insulin sensitivity in non-obese individuals with enlarged abdominal adipose cells","volume":"4","author":"Hammarstedt","year":"2012","journal-title":"Diabetol Metab Syndrome"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1993.264.2.E197","article-title":"Insulin resistance in polycystic ovary syndrome: Decreased expression of GLUT-4 glucose transporters in adipocytes","volume":"264","author":"Rosenbaum","year":"1993","journal-title":"Am J Physiology-Endocrinology And Metab"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/3.6.467","article-title":"The expression of leptin and its receptors in pre-ovulatory human follicles","volume":"3","author":"Cioffi","year":"1997","journal-title":"Mol Hum Reprod"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1177\/1933719116670265","article-title":"Leptin levels in women with polycystic ovary syndrome: A systematic review and a meta-analysis","volume":"24","author":"Zheng","year":"2017","journal-title":"Reprod Sci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.3.5543","article-title":"Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary","volume":"84","author":"Agarwal","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.845165","article-title":"Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome","volume":"13","author":"Peng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2020.1760817","article-title":"Correlation between leptin and IFN-\u0393 involved in granulosa cell apoptosis in PCOS","volume":"36","author":"Wang","year":"2020","journal-title":"Gynecological Endocrinol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1445-5781.2002.00008.x","article-title":"Relationships between circulating leptin concentrations and other hormonal parameters in obese and non-obese women with polycystic ovary syndrome","volume":"1","author":"Kikuchi","year":"2002","journal-title":"Reprod Med Biol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1324-0","article-title":"Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots","volume":"47","author":"Dicker","year":"2004","journal-title":"Diabetologia"},{"key":"B154","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1677\/joe.1.07070","article-title":"Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women","volume":"192","author":"Corbould","year":"2007","journal-title":"J Endocrinol"},{"key":"B155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-27318-1_19-1","article-title":"The endocrine gut","volume-title":"Principles of endocrinology and hormone action","author":"Rehfeld","year":"2016"},{"key":"B156","article-title":"Gut bacteria in health and disease","volume":"9","author":"Quigley","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1292125","article-title":"GLP-1 receptor agonists in the treatment of polycystic ovary syndrome","volume":"10","author":"Lamos","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2019.170183","article-title":"Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists","volume":"125","author":"Gasbjerg","year":"2020","journal-title":"Peptides"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1180","article-title":"Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome","volume":"99","author":"Chang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0097","article-title":"Incretin levels in polycystic ovary syndrome","volume":"159","author":"Vrbikova","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2019.170233","article-title":"Emerging role of GIP and related gut hormones in fertility and PCOS","volume":"125","author":"Moffett","year":"2020","journal-title":"Peptides"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519865351","article-title":"An impaired gluCAGon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity","volume":"47","author":"Ferjan","year":"2019","journal-title":"J Int Med Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2008.11.009","article-title":"Incretin hormone secretion in women with polycystic ovary syndrome: Roles of obesity, insulin sensitivity, and treatment with metformin","volume":"58","author":"Svendsen","year":"2009","journal-title":"Metabolism"},{"key":"B164","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2217\/fmb.11.142","article-title":"The relationship between gut microbiota and weight gain in humans","volume":"7","author":"Angelakis","year":"2012","journal-title":"Future Microbiol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1055\/a-1081-2036","article-title":"Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): A review","volume":"80","author":"Zhao","year":"2020","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110958","article-title":"Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype","volume":"133","author":"Wang","year":"2021","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B167","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s43032-020-00430-0","article-title":"Gut microbiota in patients with polycystic ovary syndrome: A systematic review","volume":"29","author":"Guo","year":"2022","journal-title":"Reprod Sci"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168390","article-title":"Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): A pilot study","volume":"12","author":"Lindheim","year":"2017","journal-title":"PloS One"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa848","article-title":"The gut microbiome in polycystic ovary syndrome and its association with metabolic traits","volume":"106","author":"L\u00fcll","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz263","article-title":"Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota","volume":"105","author":"Jobira","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02799","article-title":"Gut microbiota and the polycystic ovary syndrome: Influence of sex, sex hormones, and obesity","volume":"103","author":"Insenser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.808508","article-title":"Gut and vaginal microbiomes in PCOS: Implications for women's health","volume":"13","author":"Gu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B174","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/ec-19-0522","article-title":"Characteristic gut microbiota and predicted metabolic functions in women with PCOS","volume":"9","author":"Zhou","year":"2020","journal-title":"Endocr Connect"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13417","article-title":"Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population","volume":"51","author":"Mammadova","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01481-5","article-title":"Gut microbiota alterations reveal potential gut\u2013brain axis changes in polycystic ovary syndrome","volume":"44","author":"Liang","year":"2021","journal-title":"J Endocrinological Invest"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front Microbiol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.resmic.2018.09.002","article-title":"Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): A pilot study","volume":"170","author":"Zeng","year":"2019","journal-title":"Res Microbiol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00017-19","article-title":"Probiotic bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis","volume":"4","author":"Zhang","year":"2019","journal-title":"mSystems"},{"key":"B180","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13048-020-00670-3","article-title":"Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: A review","volume":"13","author":"He","year":"2020","journal-title":"J Ovarian Res"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2063","article-title":"Ghrelin inhibits steroid biosynthesis by cultured granulosa-lutein cells","volume":"93","author":"Viani","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B182","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12958-018-0354-x","article-title":"GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile","volume":"16","author":"Chaudhari","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-018-0371-5","article-title":"Lean polycystic ovary syndrome (PCOS): An evidence-based practical approach","volume":"17","author":"Toosy","year":"2018","journal-title":"J Diabetes Metab Disord"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003132","article-title":"Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis","volume":"17","author":"Dapas","year":"2020","journal-title":"PloS Med"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2040","article-title":"Renaming PCOS\u2013a two-state solution","volume":"98","author":"Dunaif","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B186","doi-asserted-by":"publisher","first-page":"A45","DOI":"10.1136\/bmjebm-2018-111070.95","article-title":"95 challenges and uncertainties regarding polycystic ovary syndrome (PCOS) and the potential for overdiagnosis: Clinicians\u2019 views and experiences","volume":"23","author":"Copp","year":"2018","journal-title":"BMJ Evidence-Based Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1017468\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T01:49:15Z","timestamp":1728352155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1017468\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":186,"alternative-id":["10.3389\/fendo.2022.1017468"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1017468","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"article-number":"1017468"}}